Stephen R. Davis has been strategic with his holdings in Acadia Pharmaceuticals. Recently, he has increased his investment in the company, owning a large number of restricted stock units (RSUs) which greatly contribute to his overall wealth. His vested stock...
Stephen R. Davis has been strategic with his holdings in Acadia Pharmaceuticals. Recently, he has increased his investment in the company, owning a large number of restricted stock units (RSUs) which greatly contribute to his overall wealth. His vested stock in 2023 was valued at approximately $3.87 million. This reflects his commitment to Acadia and also shows how closely tied his financial success is to the company's performance. Over the years, he has held a significant number of options that were issued prior to his time as CEO, indicating he was invested in the company's future from early on. His holdings have fluctuated with the company’s stock performance, further emphasizing the alignment of leadership and shareholder interests.